Algert Global LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Algert Global LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 115.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,727 shares of the medical equipment provider's stock after acquiring an additional 4,681 shares during the period. Algert Global LLC's holdings in Intuitive Surgical were worth $4,555,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its position in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after purchasing an additional 9,194 shares during the period. World Investment Advisors LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $228,000. Nordea Investment Management AB raised its position in shares of Intuitive Surgical by 31.7% in the 4th quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider's stock worth $22,632,000 after acquiring an additional 10,405 shares in the last quarter. Capital Market Strategies LLC lifted its stake in shares of Intuitive Surgical by 7.8% during the 4th quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider's stock worth $646,000 after purchasing an additional 90 shares during the last quarter. Finally, Diversified Trust Co boosted its position in Intuitive Surgical by 0.6% during the fourth quarter. Diversified Trust Co now owns 4,383 shares of the medical equipment provider's stock valued at $2,288,000 after purchasing an additional 25 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG stock traded down $1.61 during midday trading on Friday, hitting $536.55. 925,598 shares of the stock traded hands, compared to its average volume of 1,628,568. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00. The stock's fifty day simple moving average is $501.36 and its 200-day simple moving average is $534.58. The firm has a market cap of $192.31 billion, a P/E ratio of 83.71, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the firm earned $1.50 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on ISRG shares. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Royal Bank of Canada reduced their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target for the company. Finally, Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $598.95.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock worth $17,229,143 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.